The role of serotonin in nonnormative risky choice: The effects of tryptophan supplements on the "reflection effect" in healthy adult volunteers

Journal of Cognitive Neuroscience

Volumn 21, Issue 9, 2009, Pages 1709-1719

  Murphy, Susannah E ^a   Longhitano, Carlo ^a   Ayres, Rachael E ^a   Cowen, Philip J ^a   Harmer, Catherine J ^a   Rogers, Robert D ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTRANSMITTER; PLACEBO; SEROTONIN; TRYPTOPHAN;

ADULT; AFFECT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; NEUROTRANSMISSION; NORMAL HUMAN; OUTCOME ASSESSMENT; POSITIVE AND NEGATIVE AFFECT SCALE; PRIORITY JOURNAL; PROBABILITY; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; REWARD; RISK; SEROTONINERGIC SYSTEM; STATE TRAIT ANXIETY INVENTORY; STATISTICAL ANALYSIS; TASK PERFORMANCE; TIME; UNCERTAINTY;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHOICE BEHAVIOR; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GAMBLING; HUMANS; MALE; PROBABILITY; RISK-TAKING; SEROTONIN; TRYPTOPHAN; YOUNG ADULT;

AMINO ACIDS; DIETARY SUPPLEMENTS; FOOD ADDITIVES;

CONDITION; DECISIONS MAKINGS; HUMAN DECISION-MAKING; MATCHED CONTROLS; RATIONAL MODELS; REFLECTION EFFECTS; RELATIVE VALUE; RISK AVERSE; RISKY DECISIONS; UNCERTAINTY;

DECISION MAKING;

EID: 67650456231     PISSN: 0898929X     EISSN: 15308898     Source Type: Journal    
DOI: 10.1162/jocn.2009.21122     Document Type: Article

References (50)

1. Aronson, S. C., Black, J. E., McDougle, C. J., Scanley, B. E., Jatlow, P., Kosten, T. R., et al. (1995). Serotonergic mechanisms of cocaine effects in humans. Psychopharmacology (Berlin), 119, 179-185.
2. Attenburrow, M. J., Williams, C., Odontiadis, J., Reed, A., Powell, J., Cowen, P. J., et al. (2003). Acute administration of nutritionally sourced tryptophan increases fear recognition. Psychopharmacology (Berlin), 169, 104-107.
3. Bernoulli, D. (1954). Exposition of a new theory on the measurement of risk. Econometrica, 22, 23-36. (Original work published 1738).
4. Burghardt, N. S., Sullivan, G. M., McEwen, B. S., Gorman, J. M., & LeDoux, J. E. (2004). The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: A comparison with tianeptine. Biological Psychiatry, 55, 1171-1178.
5. Clarke, H. F., Walker, S. C., Crofts, H. S., Dalley, J. W., Robbins, T. W., & Roberts, A. C. (2005). Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. Journal of Neuroscience, 25, 532-538.
6. Damasio, A. R., Grabowski, T. J., Bechara, A., Damasio, H., Ponto, L. L., Parvizi, J., et al. (2000). Subcortical and cortical brain activity during the feeling of self-generated emotions. Nature Neuroscience, 3, 1049-1056.
7. David, S. P., Murthy, N. V., Rabiner, E. A., Munafo, M. R., Johnstone, E. C., Jacob, R., et al. (2005). A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. Journal of Neuroscience, 25, 2586-2590.
8. Dreher, J. C. (2007). Sensitivity of the brain to loss aversion during risky gambles. Trends in Cognitive Sciences, 11, 270-272.
9. First, M., Spitzer, R., Gibbon, M., & Williams, J. (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York: Biometrics Research.
10. Glimcher, P. W. (2001). Making choices: The neurophysiology of visual-saccadic decision making. Trends in Neurosciences, 24, 654-659.
11. Goldstein, W. M., & Hogarth, R. M. (1997). Judgment and decision research: Some historical context. In W. M. Goldstein & R. M. Hogarth (Eds.), Research on judgment and decision-making: Currents, connections and controversies (pp. 3-65). Cambridge: Cambridge University Press.
12. Graeff, F. G., Guimaraes, F. S., De Andrade, T. G., & Deakin, J. F. (1996). Role of 5-HT in stress, anxiety, and depression. Pharmacology, Biochemistry and Behavior, 54, 129-141.
13. Harmer, C. J., Bhagwagar, Z., Perrett, D. I., Vollm, B. A., Cowen, P. J., & Goodwin, G. M. (2003). Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology, 28, 148-152.
14. Harmer, C. J., Mackay, C. E., Reid, C. B., Cowen, P. J., & Goodwin, G. M. (2006). Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biological Psychiatry, 59, 816-820.
15. Harmer, C. J., Shelley, N. C., Cowen, P. J., & Goodwin, G. M. (2004). Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. American Journal of Psychiatry, 161, 1256-1263.
16. Howell, D. C. (1987). Statistical methods for psychology (2nd ed.). Boston: Duxbury Press.
17. Kent, J. M., Coplan, J. D., & Gorman, J. M. (1998). Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biological Psychiatry, 44, 812-824.
18. Khaneman, D., & Tversky, A. (1979). Prospect theory: An analysis of decision under risk. Econometrica, 47, 263-291.
19. Knutson, B., Taylor, J., Kaufman, M., Peterson, R., & Glover, G. (2005). Distributed neural representation of expected value. Journal of Neuroscience, 25, 4806-4812.
20. Montague, P. R., King-Casas, B., & Cohen, J. D. (2006). Imaging valuation models in human choice. Annual Review of Neuroscience, 29, 417-448.
21. Moore, P., Landolt, H. P., Seifritz, E., Clark, C., Bhatti, T., Kelsoe, J., et al. (2000). Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology, 23, 601-622.
22. Morgan, M. J., Impallomeni, L. C., Pirona, A., & Rogers, R. D. (2006). Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naive controls. Neuropsychopharmacology, 31, 1562-1573.
23. Moskowitz, D. S., Pinard, G., Zuroff, D. C., Annable, L., & Young, S. N. (2001). The effect of tryptophan on social interaction in everyday life: A placebo-controlled study. Neuropsychopharmacology, 25, 277-289.
24. Murphy, S. E., Longhitano, C., Ayres, R. E., Cowen, P. J., & Harmer, C. J. (2006). Tryptophan supplementation induces a positive bias in the processing of emotional material in healthy female volunteers. Psychopharmacology (Berlin), 187, 121-130.
25. Nelson, H. (1982). National Adult Reading Test (NART) Test Manual. Windsor, UK: NFER-Nelson.
26. Pessiglione, M., Seymour, B., Flandin, G., Dolan, R. J., & Frith, C. D. (2006). Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature, 442, 1042-1045.
27. Reist, C., Mazzanti, C., Vu, R., Tran, D., & Goldman, D. (2001). Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine. American Journal of Medical Genetics, 105, 363-368.
28. Rogers, R. D., Blackshaw, A. J., Middleton, H. C., Matthews, K., Hawtin, K., Crowley, C., et al. (1999). Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: Implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology (Berlin), 146, 482-491.
29. Rogers, R. D., Lancaster, M., Wakeley, J., & Bhagwagar, Z. (2004). Effects of beta-adrenoceptor blockade on components of human decision-making. Psychopharmacology (Berlin), 172, 157-164.
30. Rogers, R. D., Ramnani, N., Mackay, C., Wilson, J. L., Jezzard, P., Carter, C. S., et al. (2004). Distinct portions of anterior cingulate cortex and medial prefrontal cortex are activated by reward processing in separable phases of decision-making cognition. Biological Psychiatry, 55, 594-602.
31. Rogers, R. D., Tunbridge, E. M., Bhagwagar, Z., Drevets, W. C., Sahakian, B. J., & Carter, C. S. (2003). Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology, 28, 153-162.
32. Rogers, R. D., Wakeley, J., Robson, P. J., Bhagwagar, Z., & Makela, P. (2007). The effects of low doses of delta-9 tetrahydrocannabinol on reinforcement processing in the risky decision-making of young healthy adults. Neuropsychopharmacology, 32, 417-428.
33. Roiser, J. P., Rogers, R. D., Cook, L. J., & Sahakian, B. J. (2006). The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls. Psychopharmacology (Berlin), 188, 213-227.
34. Rolls, E. T., McCabe, C., & Redoute, J. (2008). Expected value, reward outcome, and temporal difference error representations in a probabilistic decision task. Cerebral Cortex, 18, 652-663.
35. Savage, L. J. (1954). The foundations of statistics. New York: Wiley.
36. Schultz, W. (2006). Behavioral theories and the neurophysiology of reward. Annual Review of Psychology, 57, 87-115.
37. Schultz, W., Tremblay, L., & Hollerman, J. R. (2000). Reward processing in primate orbitofrontal cortex and basal ganglia. Cerebral Cortex, 10, 272-284.
38. Shafir, E., & Tversky, A. (1995). Decision making. In E. E. Smith & D. N. Oscherson (Eds.), Thinking (pp. 77-100). Cambridge, MA: MIT Press.
39. Smith, G. S., Lotrich, F. E., Malhotra, A. K., Lee, A. T., Ma, Y., Kramer, E., et al. (2004). Effects of serotonin transporter promoter polymorphisms on serotonin function. Neuropsychopharmacology, 29, 2226-2234.
40. Spielberger, C. D., Gorsuch, R. L., & Lushene, R. D. (1983). Manual for the State-Trait Anxiety Inventory (STAI). Palo Alto, CA: Consulting Psychologists Press.
41. Tanaka, S. C., Schweighofer, N., Asahi, S., Shishida, K., Okamoto, Y., Yamawaki, S., et al. (2007). Serotonin differentially regulates short- and long-term prediction of rewards in the ventral and dorsal striatum. PLoS ONE, 2, e1333.
42. Tobler, P. N., O'Doherty, J. P., Dolan, R. J., & Schultz, W. (2007). Reward value coding distinct from risk attitude-related uncertainty coding in human reward systems. Journal of Neurophysiology, 97, 1621-1632.
43. Tom, S. M., Fox, C. R., Trepel, C., & Poldrack, R. A. (2007). The neural basis of loss aversion in decision-making under risk. Science, 315, 515-518.
44. von Neumann, J., & Morgenstern, O. (1944). Theory of games and economic behavior (3rd ed.). Princeton: Princeton University Press.
45. von Winterfeldt, D., & Edwards, W. (1986). Decision analysis and behavioral research. Cambridge: Cambridge University Press.
46. Walker, S. C., Mikheenko, Y. P., Argyle, L. D., Robbins, T. W., & Roberts, A. C. (2006). Selective prefrontal serotonin depletion impairs acquisition of a detour-reaching task. European Journal of Neuroscience, 23, 3119-3123.
47. Walsh, S. L., & Cunningham, K. A. (1997). Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine. Psychopharmacology (Berlin), 130, 41-58.
48. Watson, D., Clark, L. A., & Tellegen, A. (1988). Development and validation of brief measures of positive and negative affect: The PANAS scales. Journal of Personality and Social Psychology, 54, 1063-1070.
49. Yacubian, J., Glascher, J., Schroeder, K., Sommer, T., Braus, D. F., & Buchel, C. (2006). Dissociable systems for gain- and loss-related value predictions and errors of prediction in the human brain. Journal of Neuroscience, 26, 9530-9537.
50. Young, S. N., & Gauthier, S. (1981). Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal f luid. Journal of Neurology, Neurosurgery and Psychiatry, 44, 323-328.